Keros Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 7.3, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Keros Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 50 days, from 14 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 123 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 239 to 1255.

What is Receivable Turnover Ratio?
What is Keros Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KROS Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-97.69 %	30.09 %	800 %	395300 %	7550.88 %
Y / Y Revenue Change	-98.76 %	-95.97 %	242.91 %	235.51 %	3602.46 %
Receivable Turnover Ratio (TTM)	7.3	25.67	27.14	27.81	46.84
KROS's Total Ranking	# 1255	# 239	# 246	# 276	#
Accounts Receivable average collection period days	50	14	13	13	8
Seq. Receivable Change	-88.79 %	2.15 %	-77.92 %	-8.53 %	530.6 %
Seq. Revenue Change	601.82 %	-98.18 %	16.66 %	-91.67 %	2180.49 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 45
Healthcare Sector	# 124
Overall Market	# 1255

Receivable Turnover Ratio Statistics
High	Average	Low
281.07	77.65	9.44
(Jun 30 2024)		(Mar 31 2026)

KROS Company Profile • Back to KROS Efficiency Comparisons • Compare KROS Receivables Turnover Ratio to its Competitors

Financial Statements
Keros Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit KROS's Balance sheet
Keros Therapeutics Inc 's Sales TTM	$ 42 Millions	Visit KROS's Income Statement
Sources of KROS's Revenues		Visit KROS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KROS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KROS's Growth Rates	KROS's Roa	KROS's Inventory Turnover Ratio	KROS's Dividend Comparisons
KROS's Profitability Ratios	KROS's Roi	KROS's Asset Turnover Ratio	KROS's Dividend Growth
KROS's Valuation Ratios	KROS's Roe	KROS's Financial Strength Ratios	KROS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Logicmark Inc	284.46	$ 12.048 Millions	$ 0.042 Millions
Dr Reddy s Laboratories Limited	275.38	$ 3,580.000 Millions	$ 13.000 Millions
Ainos Inc	246.41	$ 0.018 Millions	$ 0.000 Millions
Ginkgo Bioworks Holdings Inc	218.58	$ 141.311 Millions	$ 0.647 Millions
Fortress Biotech Inc	192.61	$ 66.161 Millions	$ 0.344 Millions
Arcus Biosciences Inc	188.80	$ 236.000 Millions	$ 1.250 Millions
Immunocore Holdings Plc	186.94	$ 412.812 Millions	$ 2.208 Millions
Aclaris Therapeutics Inc	172.52	$ 8.367 Millions	$ 0.049 Millions
Hcw Biologics Inc	165.47	$ 6.592 Millions	$ 0.040 Millions
Prime Medicine Inc	134.47	$ 4.034 Millions	$ 0.030 Millions
Earth Science Tech Inc	127.94	$ 33.712 Millions	$ 0.263 Millions
Lenz Therapeutics Inc	124.93	$ 20.989 Millions	$ 0.168 Millions
Agape Atp Corporation	123.42	$ 1.509 Millions	$ 0.012 Millions
Assembly Biosciences Inc	121.69	$ 71.097 Millions	$ 0.584 Millions
Bridgebio Oncology Therapeutics Inc	114.95	$ 15.288 Millions	$ 0.133 Millions
Harvard Apparatus Regenerative Technology Inc	88.50	$ 0.885 Millions	$ 0.010 Millions
Zeo Scientifix Inc	74.53	$ 6.987 Millions	$ 0.094 Millions
Airsculpt Technologies Inc	69.52	$ 151.836 Millions	$ 2.184 Millions
Sbc Medical Group Holdings Incorporated	64.95	$ 167.536 Millions	$ 2.579 Millions
Arrowhead Pharmaceuticals Inc	63.74	$ 622.009 Millions	$ 9.758 Millions
Hims and Hers Health Inc	63.35	$ 2,369.476 Millions	$ 37.405 Millions
Spero Therapeutics Inc	59.36	$ 61.186 Millions	$ 1.031 Millions
Humacyte Inc	58.59	$ 34.376 Millions	$ 0.587 Millions
Aim Immunotech Inc	53.71	$ 0.094 Millions	$ 0.002 Millions
Brookdale Senior Living Inc	49.21	$ 3,145.058 Millions	$ 63.914 Millions
Fortrea Holdings Inc	44.31	$ 2,708.600 Millions	$ 61.125 Millions
National Vision Holdings Inc	41.80	$ 2,021.044 Millions	$ 48.351 Millions
Metagenomi Therapeutics Inc	41.78	$ 22.331 Millions	$ 0.535 Millions
Mangoceuticals Inc	41.34	$ 0.415 Millions	$ 0.010 Millions
Nature s Sunshine Products inc	39.69	$ 489.104 Millions	$ 12.324 Millions

Date modified: 2026-08-29T17:41:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.